Integration of Smad and MAPK pathways: a link and a linker revisited.
Massague
Joan
J
Cancer Biology and Genetics Program, and Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. j.massague@ski.mskcc.org
D000818:Animals; D052004:Bone Morphogenetic Protein Receptors; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism*; D004625:Embryo, Nonmammalian; D004627:Embryonic Induction; D051524:Fibroblast Growth Factor 8; D005346:Fibroblast Growth Factors / Q000494:pharmacology; D007335:Insulin-Like Growth Factor II / Q000494:pharmacology*; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D010766:Phosphorylation; D017978:Receptors, Growth Factor / Q000037:antagonists & inhibitors; D015398:Signal Transduction; D051785:Smad Proteins; D015534:Trans-Activators / Q000378:metabolism*
D019485:Bone Morphogenetic Proteins; D004268:DNA-Binding Proteins; C496457:Fgf8 protein, mouse; D017978:Receptors, Growth Factor; D051785:Smad Proteins; D015534:Trans-Activators; D051524:Fibroblast Growth Factor 8; D005346:Fibroblast Growth Factors; D007335:Insulin-Like Growth Factor II; D020928:Mitogen-Activated Protein Kinases; D052004:Bone Morphogenetic Protein Receptors